XML 70 R56.htm IDEA: XBRL DOCUMENT v3.23.3
Segment Data Segment Data - Revenues by Geographic Areas (Details) - USD ($)
$ in Millions
12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2021
Segment Reporting Information [Line Items]      
Revenues $ 19,372 $ 18,870 $ 19,131
Operating Segments | Medical      
Segment Reporting Information [Line Items]      
Revenues 9,502 8,841 8,361
Operating Segments | Life Sciences      
Segment Reporting Information [Line Items]      
Revenues 5,133 5,564 6,530
Operating Segments | Interventional      
Segment Reporting Information [Line Items]      
Revenues 4,736 4,464 4,239
United States      
Segment Reporting Information [Line Items]      
Revenues 11,113 10,722 10,371
United States | Operating Segments | Medical      
Segment Reporting Information [Line Items]      
Revenues 5,488 4,950 4,544
United States | Operating Segments | Life Sciences      
Segment Reporting Information [Line Items]      
Revenues 2,377 2,732 2,980
United States | Operating Segments | Interventional      
Segment Reporting Information [Line Items]      
Revenues 3,247 3,040 2,847
Non-US      
Segment Reporting Information [Line Items]      
Revenues 8,258 8,148 8,760
Non-US | Operating Segments | Medical      
Segment Reporting Information [Line Items]      
Revenues 4,014 3,891 3,817
Non-US | Operating Segments | Life Sciences      
Segment Reporting Information [Line Items]      
Revenues 2,756 2,833 3,550
Non-US | Operating Segments | Interventional      
Segment Reporting Information [Line Items]      
Revenues 1,489 1,424 1,392
Medication Delivery Solutions | Operating Segments | Medical      
Segment Reporting Information [Line Items]      
Revenues 4,293 4,308 4,101
Medication Delivery Solutions | United States | Operating Segments | Medical      
Segment Reporting Information [Line Items]      
Revenues 2,519 2,483 2,253
Medication Delivery Solutions | Non-US | Operating Segments | Medical      
Segment Reporting Information [Line Items]      
Revenues 1,774 1,825 1,848
Medication Management Solutions | Operating Segments | Medical      
Segment Reporting Information [Line Items]      
Revenues 2,980 2,533 2,432
Medication Management Solutions | United States | Operating Segments | Medical      
Segment Reporting Information [Line Items]      
Revenues 2,303 1,935 1,863
Medication Management Solutions | Non-US | Operating Segments | Medical      
Segment Reporting Information [Line Items]      
Revenues 677 598 570
Pharmaceutical Systems | Operating Segments | Medical      
Segment Reporting Information [Line Items]      
Revenues 2,229 2,001 1,828
Pharmaceutical Systems | United States | Operating Segments | Medical      
Segment Reporting Information [Line Items]      
Revenues 666 533 428
Pharmaceutical Systems | Non-US | Operating Segments | Medical      
Segment Reporting Information [Line Items]      
Revenues 1,563 1,468 1,400
Integrated Diagnostic Solutions | Operating Segments | Life Sciences      
Segment Reporting Information [Line Items]      
Revenues 3,624 4,185 5,225
Integrated Diagnostic Solutions | United States | Operating Segments | Life Sciences      
Segment Reporting Information [Line Items]      
Revenues 1,774 2,190 2,477
Integrated Diagnostic Solutions | Non-US | Operating Segments | Life Sciences      
Segment Reporting Information [Line Items]      
Revenues 1,850 1,995 2,748
Biosciences | Operating Segments | Life Sciences      
Segment Reporting Information [Line Items]      
Revenues 1,509 1,379 1,305
Biosciences | United States | Operating Segments | Life Sciences      
Segment Reporting Information [Line Items]      
Revenues 603 542 503
Biosciences | Non-US | Operating Segments | Life Sciences      
Segment Reporting Information [Line Items]      
Revenues 906 838 802
Surgery | Operating Segments | Interventional      
Segment Reporting Information [Line Items]      
Revenues 1,497 1,400 1,296
Surgery | United States | Operating Segments | Interventional      
Segment Reporting Information [Line Items]      
Revenues 1,159 1,094 1,023
Surgery | Non-US | Operating Segments | Interventional      
Segment Reporting Information [Line Items]      
Revenues 338 306 274
Peripheral Intervention | Operating Segments | Interventional      
Segment Reporting Information [Line Items]      
Revenues 1,865 1,759 1,711
Peripheral Intervention | United States | Operating Segments | Interventional      
Segment Reporting Information [Line Items]      
Revenues 1,016 960 931
Peripheral Intervention | Non-US | Operating Segments | Interventional      
Segment Reporting Information [Line Items]      
Revenues 849 799 780
Urology and Critical Care | Operating Segments | Interventional      
Segment Reporting Information [Line Items]      
Revenues 1,374 1,305 1,232
Urology and Critical Care | United States | Operating Segments | Interventional      
Segment Reporting Information [Line Items]      
Revenues 1,073 986 894
Urology and Critical Care | Non-US | Operating Segments | Interventional      
Segment Reporting Information [Line Items]      
Revenues $ 301 $ 319 $ 338